We describe a case of leucocytoclasic vasculitis induced by Sofosbuvir and its disappearence after the end of the therapy. The hepatitis C virus, firstly described in 1989, is a major global health problem, with high morbidity and mortality. We observed a temporal relationship between the treatment and the onset of vasculitis. We emphasize the multidisciplinary approach to the patients with liver disease to improve the quality of life of these patients.
Campione, E., Dattola, A., Di Prete, M., Di Paolo, D., Ferlosio, A., Orlandi, A., et al. (2019). Sofosbuvir induced leucocytoclasic vasculitis: a case report. BMC DERMATOLOGY, 19(1), 6 [10.1186/s12895-019-0086-4].
Sofosbuvir induced leucocytoclasic vasculitis: a case report
Campione, Elena;Di Paolo, Daniele;Ferlosio, Amedeo;Orlandi, Augusto;Bianchi, Luca
2019-05-17
Abstract
We describe a case of leucocytoclasic vasculitis induced by Sofosbuvir and its disappearence after the end of the therapy. The hepatitis C virus, firstly described in 1989, is a major global health problem, with high morbidity and mortality. We observed a temporal relationship between the treatment and the onset of vasculitis. We emphasize the multidisciplinary approach to the patients with liver disease to improve the quality of life of these patients.| File | Dimensione | Formato | |
|---|---|---|---|
|
Sofosbuvir induced leucocytoclasic.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
730.15 kB
Formato
Adobe PDF
|
730.15 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
